CVS Health Helps Improve Access to More Affordable Fertility Treatments
Accessibility StatementSkip Navigation Gonal-F will offer a more competitive price on the TrumpRx platform. Because the program will not launch until 2026, there may be changes to which drugs and which manufacturers will support competitive cash rates through this platform. What are the benefits for patients? WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specia ...